Julio Chavez
0000-0002-2045-6238
Moffitt Cancer Center
5 papers found
Refreshing results…
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial
EBV ‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management
Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy
Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study
Missing publications? Search for publications with a matching author name.